Danaher Corporation $DHR Shares Acquired by Whittier Trust Co. of Nevada Inc.

Whittier Trust Co. of Nevada Inc. increased its position in Danaher Corporation (NYSE:DHR) by 6.1% in the 1st quarter, Holdings Channel.com reports. The firm owned 133,764 shares of the conglomerate’s stock after buying an additional 7,647 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in Danaher were worth $25,699,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. JPL Wealth Management LLC acquired a new position in Danaher in the 3rd quarter worth $25,000. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher during the fourth quarter valued at about $26,000. WFA of San Diego LLC purchased a new stake in shares of Danaher during the second quarter worth about $26,000. Hilton Head Capital Partners LLC purchased a new stake in shares of Danaher during the fourth quarter worth about $27,000. Finally, Clal Insurance Enterprises Holdings Ltd lifted its stake in shares of Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 53 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 0.0%

NYSE:DHR opened at $197.85 on Monday. The company has a market cap of $140.03 billion, a PE ratio of 38.27, a P/E/G ratio of 2.52 and a beta of 0.79. The business’s 50 day moving average is $179.01 and its two-hundred day moving average is $200.34. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The business had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business’s quarterly revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.88 EPS. On average, analysts predict that Danaher Corporation will post 8.44 EPS for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Citigroup began coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target for the company. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Jefferies Financial Group reiterated a “buy” rating and set a $245.00 target price on shares of Danaher in a research note on Tuesday, April 21st. Wells Fargo & Company decreased their price target on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 22nd. Finally, UBS Group dropped their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.